tiprankstipranks
Trending News
More News >
Defence Therapeutics (TSE:DTC)
:DTC
Canadian Market

Defence Therapeutics (DTC) Income Statement

Compare
10 Followers

Defence Therapeutics Income Statement

Last quarter (Q1 2026), Defence Therapeutics's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, Defence Therapeutics's net income was C$-703.00K. See Defence Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -72.34KC$ -90.92KC$ -13.82KC$ 0.00C$ 0.00
Operating Expenses
C$ 3.20MC$ 12.66MC$ 6.48MC$ 3.56MC$ 2.86M
Depreciation and Amortization
C$ 72.34KC$ 70.94KC$ 13.82KC$ 7.27MC$ 2.83M
EBITDA
C$ -3.13MC$ -12.68MC$ -6.48MC$ 0.00C$ 0.00
Operating Income
C$ -3.27MC$ -12.66MC$ -6.55MC$ -3.56MC$ -2.86M
Other Income/Expenses
C$ -253.20KC$ -537.24KC$ -322.42KC$ -3.78MC$ 0.00
Pretax Income
C$ -3.52MC$ -13.19MC$ -6.87MC$ -7.34MC$ -2.86M
Net Income
C$ -3.52MC$ -13.19MC$ -6.76MC$ -7.34MC$ -2.86M
Per Share Metrics
Basic EPS
C$ -0.07C$ -0.30C$ -0.17C$ -0.20C$ -0.11
Diluted EPS
C$ -0.07C$ -0.30C$ -0.17C$ -0.20C$ -0.11
Weighted Average Shares Outstanding
49.83M 44.63M 39.66M 36.08M 26.60M
Weighted Average Shares Outstanding (Diluted)
49.83M 44.63M 39.66M 36.08M 26.60M
Currency in CAD

Defence Therapeutics Earnings and Revenue History